Pharming Group N.V. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 159.63M189.39M212.17M198.87M205.62M245.32M297.20M
Cost of Revenue 26.23M23.93M23.54M21.14M17.56M25.21M35.40M
Gross Profit 133.43M165.46M188.63M177.73M188.06M220.10M261.80M
Operating items
Research & Development 34.12M31.79M38.52M70.40M52.53M68.91M83.15M
Share-based Compensation (IS) 11.25M
Selling, General & Administrative 14.44M21.19M24.09M36.97M46.02M55.88M70.65M
Operating Expenses 48.56M52.98M62.60M107.37M98.55M124.79M153.80M
Operating Income 44.88M68.25M76.26M13.56M18.23M-5.39M-8.62M
EBIT 44.88M68.25M76.26M13.56M18.23M-5.39M-8.62M
Non-operating items
Interest & Investment Income 0.54M0.80M
Other Non Operating Income -0.58M-0.23M0.07M0.11M-1.19M-0.93M4.99M
Non Operating Income -43.87M-16.20M-32.52M8.82M-2.16M-6.34M1.89M
Net income details
EBT 1.01M52.30M44.09M0.02M23.79M-4.59M-8.62M
Tax Provisions -28.51M11.75M6.35M7.08M1.31M-1.46M3.35M
Profit After Tax 29.52M40.56M37.75M16.00M13.67M-10.55M-11.84M
Equity Income 0.26M0.36M0.69M-1.08M-0.29M-1.76M
Investment Income -0.04M0.01M-14.80M-10.35M5.91M-6.12M
Income from Continuing Operations 29.52M40.56M37.75M-7.06M22.48M-3.12M-11.97M
Consolidated Net Income 29.52M40.56M37.75M-7.06M22.48M-3.12M-11.97M
Income towards Parent Company 29.52M40.56M37.75M-7.06M22.48M-3.12M-11.97M
Net Income towards Common Stockholders 29.52M40.56M37.75M-7.06M22.48M-3.12M-11.97M
Additional items
EPS (Basic) 0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 638.06M638.06M638.82M656.35M659.18M678.35M
Shares Outstanding (Diluted Average) 842.95M901.88M724.06M
EBITDA 44.88M68.25M76.26M13.56M18.23M-5.39M-8.62M
Tax Rate 22.46%14.40%5.52%31.91%